India Greenlights First Dengue Vaccine, Qdenga: A Major Step in Public Health Battle
India has officially approved its first-ever dengue vaccine, Qdenga, from Japanese pharmaceutical giant Takeda, marking a significant milestone in the country's fight against the rapidly spreading mosquito-borne disease. The Central Drugs Standard Control Organisation (CDSCO) and the Drug Controller General of India (DCGI) granted marketing authorisation for the Dengue Tetravalent Vaccine-Qdenga, which is designed to protect individuals aged 4 to 60 years against all four dengue virus serotypes without needing prior infection screening. This move is a game-changer for a nation that bears nearly one-third of the global dengue burden.
















